Medtronic may have found a buyer for the patient monitoring and respiratory interventions businesses it put on the block about a year ago.
Citing “people familiar with the matter,” Reuters reported that Medtronic expects to sell the two businesses to private equity firm Carlyle Group for at least $7bn
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?